Financial Consulate’s Harmony Biosciences HRMY Stock Holding History

Financial Consulate’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$118	Buy	+3	New	+$116	﹤0.01%	1786

Other funds holding HRMY

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Hedeker Wealth Lincolnshire, Illinois $545M AUM 27.48% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Financial Consulate's HRMY Position: Q3 2026 in Review

Financial Consulate opened a new position in Harmony Biosciences (HRMY) in Q3 2026: 3 shares worth $118. The stake represents ﹤0.01% of the portfolio and ranks #1786 among its holdings.

52 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

Financial Consulate held 3 shares of Harmony Biosciences worth $118 as of Q3 2026.
Harmony Biosciences was a new Financial Consulate position in Q3 2026.
Harmony Biosciences made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1786 holding.
52 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.